Dihydropyridine Calcium Channel Blocker [EPC]

40947 reported adverse events

Drugs of this class: NIFEDIPINE FELODIPINE NIMODIPINE ISRADIPINE NISOLDIPINE AMLODIPINE AND VALSARTAN FELODIPINE EXTENDED-RELEASE TABLETS AMLODIPINE AND OLMESARTAN MEDOXOMIL CLEVIDIPINE CLEVIPIDINE OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/10/25 MG OLMESARTAN MEDOXOMIL, AMLODIPINE AND HYDROCHLOROTHIAZIDE TABLET 40/5/25 MG

These side effects are most commonly reported by patients taking drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class:

# Side effect Count
0 DYSPNOEA 2236
1 NAUSEA 1956
2 DRUG INEFFECTIVE 1932
3 FATIGUE 1888
4 DIARRHOEA 1782
5 DIZZINESS 1775
6 HEADACHE 1664
7 PAIN 1476
8 ASTHENIA 1435
9 HYPERTENSION 1420
See all common reactions for Dihydropyridine Calcium Channel Blocker [EPC]

Drugs of the Dihydropyridine Calcium Channel Blocker [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 67 0.0964
1 NEPHROGENIC ANAEMIA 252 0.0734
2 BLOOD PRESSURE DIASTOLIC ABNORMAL 51 0.0669
3 HYPERPARATHYROIDISM SECONDARY 116 0.0639
4 BLOOD PRESSURE SYSTOLIC ABNORMAL 45 0.0567
5 BRADYCARDIA FOETAL 30 0.0551
6 BEZOAR 36 0.0499
7 MALIGNANT HYPERTENSION 34 0.0486
8 GINGIVAL HYPERPLASIA 29 0.0481
9 RENAL ARTERY STENOSIS 49 0.0474
See all enriched reactions for Dihydropyridine Calcium Channel Blocker [EPC]